Alfresa Holdings Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
15,610
- Stock Symbol
-
2784
- Investments
-
42
- Share Price
-
$14.56
- (As of Friday Closing)
Alfresa Holdings General Information
Description
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
Contact Information
Website
www.alfresa.comCorporate Office
- 1-1-3 Otemachi
- Chiyoda-ku
- Tokyo, 100-0004
- Japan
Corporate Office
- 1-1-3 Otemachi
- Chiyoda-ku
- Tokyo, 100-0004
- Japan
Alfresa Holdings Stock Performance
As of 20-Nov-2026, Alfresa Holdings’s stock price is $14.56. Its current market cap is $2.55B with 175M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $14.56 | $14.78 | $13.19 - $17.23 | $2.55B | 175M | 440K | $1.35 |
Alfresa Holdings Financials Summary
As of 30-Sep-2026, Alfresa Holdings has a trailing 12-month revenue of $20.1B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 1,511,017 | 1,671,205 | 1,431,293 | 1,604,439 |
| Revenue | 20,059,637 | 20,594,232 | 19,416,968 | 19,783,398 |
| EBITDA | 473,410 | 511,083 | 356,837 | 397,135 |
| Net Income | 244,403 | 276,968 | 179,602 | 204,568 |
| Total Assets | 9,760,132 | 9,427,217 | 9,622,176 | 9,564,751 |
| Total Debt | 190,578 | 222,823 | 237,533 | 230,836 |
Alfresa Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Alfresa Holdings Patents
Alfresa Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-240848-U | Extractor applicable in the disassembly of hormi-gon and similar formwork. | Active | 19-Jan-1979 | ||
| ES-240847-U | Perfected arrangement for the assembly of concrete and similar formwork. | Active | 19-Jan-1979 | ||
| ES-240847-Y | Perfected arrangement for the assembly of concrete forms and the like. | Inactive | 19-Jan-1979 | ||
| ES-237026-U | Device for the assembly of concrete and similar formwork. | Active | 30-Jun-1978 | ||
| ES-226543-U | Tone frequency modulator. | Active | 19-Feb-1977 |
Alfresa Holdings Signals
Alfresa Holdings Investments & Acquisitions (42)
Alfresa Holdings’s most recent deal was a PIPE with Mycenax for . The deal was made on 09-Nov-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mycenax | 09-Nov-2026 | PIPE | Biotechnology | ||
| Sega Sammy Holdings (Sega Sammy Baseball Club) | 14-Jul-2026 | Merger/Acquisition | Education and Training Services (B2B) | ||
| Nagashima Medical Instruments | 27-May-2026 | Merger/Acquisition | Surgical Devices | ||
| ReeNT | 27-May-2026 | Later Stage VC | Drug Discovery | ||
| Intellim (Staffing Business, Cro Outsourcing and Contracting Business) | 31-Mar-2026 | Merger/Acquisition | BPO/Outsource Services |
Alfresa Holdings ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
16.82 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Distribution
Subindustry
of 42
Rank
Percentile
Alfresa Holdings Exits (3)
Alfresa Holdings’s most recent exit was on 21-Aug-2025 from Innovacell. The exit was categorized as with 9 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Innovacell | 21-Aug-2025 | Completed |
|
||
| NC Medical Research | 05-Aug-2021 | Completed |
|
||
| Taishodo | 01-Jul-2004 | Merger/Acquisition | Completed |
Alfresa Holdings Affiliates
Subsidiaries (14)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ArkMS | Tokyo, Japan | 2024 | |
| Tohoku Alfressa | Sendai City, Japan | 2018 | |
| Alfresa System Kk | Tokyo, Japan | 2007 | |
| Astrana Health | Alhambra, CA | 1992 | |
| Techno Suzuta | Nagasaki, Japan | 1953 |
Alfresa Holdings FAQs
-
When was Alfresa Holdings founded?
Alfresa Holdings was founded in 2003.
-
Where is Alfresa Holdings headquartered?
Alfresa Holdings is headquartered in Tokyo, Japan.
-
What is the size of Alfresa Holdings?
Alfresa Holdings has 15,610 total employees.
-
What industry is Alfresa Holdings in?
Alfresa Holdings’s primary industry is Holding Companies.
-
Is Alfresa Holdings a private or public company?
Alfresa Holdings is a Public company.
-
What is Alfresa Holdings’s stock symbol?
The ticker symbol for Alfresa Holdings is 2784.
-
What is the current stock price of Alfresa Holdings?
As of 20-Nov-2026 the stock price of Alfresa Holdings is $14.56.
-
What is the current market cap of Alfresa Holdings?
The current market capitalization of Alfresa Holdings is $2.55B.
-
What is Alfresa Holdings’s current revenue?
The trailing twelve month revenue for Alfresa Holdings is $20.1B.
-
What is Alfresa Holdings’s annual earnings per share (EPS)?
Alfresa Holdings’s EPS for 12 months was $1.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process